Quick Answer
Perspective Therapeutics, Inc. reported Net Income of -$103.12 million for fiscal year 2025.
Perspective Therapeutics, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$103.12M | -30.1% |
| 2024 | -$79.28M | -70.5% |
| 2023 | -$46.51M | -332.2% |
| 2022 | -$10.76M | -48.0% |
| 2022 | -$7.27M | -114.7% |
| 2021 | -$3.39M | +1.7% |
| 2020 | -$3.45M | +33.0% |
| 2019 | -$5.14M | +23.2% |
| 2018 | -$6.70M | -8.7% |
| 2017 | -$6.16M | -30.8% |
| 2016 | -$4.71M | -28.0% |
| 2015 | -$3.68M | +38.2% |
| 2014 | -$5.96M | -54.5% |
| 2013 | -$3.86M | -10.5% |
| 2012 | -$3.49M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$25.97M | -71.7% | -20.9% |
| June 30, 2025 | -$21.48M | -83.6% | -18.2% |
| March 31, 2025 | -$18.18M | -48.0% | -20.2% |
| September 30, 2024 | -$15.12M | -46.0% | -29.2% |
| June 30, 2024 | -$11.70M | -5.4% | +4.7% |
| March 31, 2024 | -$12.28M | -3211.1% | -18.6% |
| September 30, 2023 | -$10.36M | -154.6% | +6.8% |
| June 30, 2023 | -$11.11M | -434.5% | -2893.5% |
- Perspective Therapeutics, Inc. showed a decrease of -30.1% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, Perspective Therapeutics, Inc.’s net income has declined by 2855.7% (from -$3.49 million to -$103.12 million).
- The most recent figure is from Perspective Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: